New machine-learning approach could speed precision drug development
The approach, detailed this week in the journal Nature, uses a platform called Molecular Surface Interaction Fingerprinting (MaSIF) to design custom proteins that bind to drug-bound target proteins.
Tempus AI unveils new generative AI tools for clinical care and research
Tempus unveiled the new AI tools during the 2025 J.P. Morgan Healthcare Conference in San Francisco.
CES 2025: 9 interesting consumer health devices
Some health-tech devices to watch from the 2025 Consumer Electronics Show.
AI-enabled CGM app shows promise for glycemic control, weight management
The broader implications of this study suggest that digital health platforms like January V2 have the potential to play a crucial role in the future of chronic disease management,” the authors write.
FDA clears ARC-EX, Onward Medical’s non-invasive spinal cord stimulation system
ARC-EX is the first FDA-approved technology shown to improve hand strength and sensation patients more than one year post-injury.
HeartBeam secures FDA clearance for at-home ECG system
HeartBeam plans to initiate an Early Access Program to gather feedback from patients and physicians prior to a commercial launch.
Microbot Medical submits 510(k) to FDA for Liberty endovascular robotic system
With remote control functionality, Liberty is designed to reduce radiation exposure for physicians and staff and improve ergonomics during procedures.
How AI is used in health care today — and how it may be used in the future
A new report found that AI in health care settings is primarily used for administrative tasks, with clinical applications still in the early stages of adoption.
If Trump's tariffs go through, medical device costs will rise, analysis finds
With the majority of devices manufactured outside the United States, any increase in tariffs is likely to drive up health care costs, according to a GlobalData analysis.
FDA clears AI software for brain MRI for Multiple Sclerosis assessment
Through AI technology, Neurophet AQUA now provides multiple sclerosis (MS) analysis with a combination of lesion quantification and enhanced segmentation of T2-FLAIR MRI.
FDA issues de novo clearance for SonoMotion’s Stone Clear device, for kidney stone treatment
Stone Clear is the first and only device cleared by the FDA that uses external ultrasound pulses to facilitate passage of post-lithotripsy kidney stone fragments without surgery.
FDA Approves Johnson & Johnson’s VARIPULSE Pulsed Field Ablation Platform for AFib
The approval is based on results from the admIRE study, which showed 100% of atrial fibrillation patients achieved acute procedural success.
Dermasensor, a handheld AI device, can help physicians screen for skin cancer
Dermatologist Rebecca Hartman, MD, MPH, explains how DermaSensor is designed to scan and assess skin lesions to aid cancer screening efforts.
Michelle Tarver named new FDA device chief
Tarver takes over the lead role at CDRH after serving as interim director since July.
FDA approves Novocure’s Optune Lua, a wearable device to disrupt lung cancer cells
FDA approval of Optune Lua follows the Phase 3 LUNAR trial, showing significant improvement in median overall survival for metastatic NSCLC patients.
True Digital Surgery Appoints Kevin T. Foley as Chief Medical Officer
As chief medical officer, Foley is expected to guide the clinical direction of True Digital Surgery and the advancement of its Digital Surgical Exoscope Platform.
Alex Therapeutics and Navamedic Partner For Companion App for Parkinson’s Treatment
The app will work alongside prescription drug treatment Flexilev.
FDA Clears Zynex’s TensWave for Transcutaneous Electrical Nerve Stimulation Therapy
The TensWave is designed to provide user-friendly pain relief, complementing Zynex’s NexWave electrotherapy device.
Research Highlights Key Advancements in Implementing Adaptive Deep Brain Stimulation for Parkinson Disease
Multiple studies show that an adaptive deep brain stimulation system reduced symptoms associated with Parkinson disease by 50%.
MTD Group Acquires Ypsomed's Pen Needles, Blood Glucose Monitoring Systems
The acquisition of Ypsomed’s pen needles and blood glucose monitoring system is expected to increase MTD’s production capacity to over 2.5 billion units.
FDA Approves Medtronic’s Simplera Continuous Glucose Monitor, Announces Partnership with Abbott
Partnership with Abbott for Simplera CGM will expand access to the advanced automated insulin delivery.
Johnson & Johnson MedTech Launches Velys Active Robotic-Assisted System for Planning, Instrumenting Spinal Fusion Procedures
Velys recently received 510(k) clearance from the FDA for planning and instrumenting spinal fusion procedures across the cervical, thoracolumbar, and sacroiliac spine.
AvaSure Acquires Ouva and Adds Smart Room Solutions to its Platform
Ouva’s AI-powered technology will be added to AvaSure’s digital platform.
FDA Clears Positrigo’s NeuroLF Brain PET System for the Diagnosis of Multiple Brain Disorders
Clearance of the NeuroLF Brain PET system marks Positrigo’s first device of its kind to be approved in the United States.
AI-Controlled Virtual Assistant Announced for Digital Health Network for Self-Funded Healthcare Plans
Empara’s virtual assistant is the latest attempt to use AI to simplify the user experience in the healthcare industry.
FDA Approves Cordis’ Vascular Closure Device for Cardiac Ablation Procedures
Approval of the Mynx Control Venous vascular closure device was based on results from the ReliaSeal trial, which demonstrated 100% procedural and device success in cardiac ablation procedures.
FDA Grants Premarket Approval to Endotronix’s Cordella Pulmonary Artery Sensor System to Support Patients with Heart Failure
Cordella is the first pulmonary artery pressure-guided platform indicated for home-based comprehensive heart failure patient management.
Aidoc AI Software Used to Reduce Missed Follow Up Appointments
The company announced updates to its software to focus on this issue.
FDA Clears Two Abbott Glucose Monitoring Systems
Both systems are over-the-counter products that provide continuous glucose monitoring.
Evolution Optiks Receives FDA 510(k) Clearance for LFR-260 as the First Light Field Powered Subjective Tele-Fractor
According to the manufacturer, the LFR-260 features advanced technology that allows patients to compare multiple prescriptions simultaneously, eliminating the need for traditional refraction methods.
